Aims-To examine the reliability of international normalised ratio (INR) determination on samples stored as whole blood for up to two days at room temperature. Methods-The INR of 40 patients receiving oral anticoagulants was determined on fresh blood and on samples stored for 24 and 48 hours, using five locally calibrated prothrombin time systems. These incorporated Manchester reagent, Recombiplastin, IL PT Fibrinogen HS Plus, Manchester combined capillary prothrombin time reagent, and a freeze dried in-house reference rabbit brain thromboplastin, RBT 1010. In addition, factors II, V, VII, and X were determined on samples obtained from 18 of these patients before and after incubation at room temperature. Results-The INR of the samples changed by diVering amounts during storage, depending on which system was employed. Although the mean change after 24 hours storage was relatively small, there were individual samples that changed by > 0.5 INR with all systems. These changes would lead to adjustment in dosage of certain patients. After 48 hours these eVects were greater with all systems except that employing Recombiplastin. There were only small reductions in the measured factors by 48 hours. Conclusions-After storage of samples for only 24 hours, some patients' INR changed suYciently to aVect dosage. In view of these observations, the practice of storing whole blood samples for INR determination cannot be recommended.
The demand for laboratory monitoring of oral anticoagulant treatment is increasing as more patients are treated. One important reason for the increase is that the value of warfarin in reducing the risk of ischaemic stroke in high risk patients with atrial fibrillation is now widely accepted.
1 Age is considered one such high risk factor. 2 The prevalence of atrial fibrillation increases with age, from 0.5% at 59 years of age to more than 5% in patients over 70 years of age. More elderly patients are now therefore being prescribed anticoagulants. This has increased the pressure on those responsible for anticoagulant management to consider monitoring systems which are suitable for use in the community or in primary care, thus avoiding transporting non-ambulant patients to hospital outpatient anticoagulant clinics. Expansion of anticoagulant clinics and the extension of access through "drop in" clinics have been employed with some success to cope with increased demand. Some attempts have also been made to shift the service into primary care. This has not been widespread, however. Taylor et al reported that general practitioners were concerned about resources and lack of expertise. 3 Fitzmaurice et al believed that computerised dosing was of benefit in guiding the management of long term anticoagulation in primary care. 4 Baglin et al have considered an alternative approach. 5 They have shown that a system based on taking blood samples from patients and transporting these to the laboratory for testing resulted in dose control at least equal to that in a completely hospital based clinic. An advantage of this technique is that the normal laboratory quality assurance may be maintained. Such systems, however, depend on the reliability of international normalised ratio (INR) determination on samples that may be many hours old.
In this study we examined the changes in INR and in factors II, V, VII, and X in samples stored as whole blood for up to 48 hours.
Methods
Blood obtained by venepuncture from 40 patients receiving oral anticoagulant treatment Three tubes were taken from each patient. Prothrombin times were determined fresh (tube 1) and on samples stored at room temperature for 24 hours (tube 2) and for 48 hours (tube 3).
Various system combinations of thromboplastin reagent were used with manual or coagulometer technique. These were:
(1) Freeze dried rabbit brain thromboplastin (RBT 1010, Thrombosis Reference Centre, Manchester, UK) and manual method. 6 INR values were calculated using these system ISI and mean normal prothrombin time (MNPT) values (see table 1). Each system was controlled by testing normal and abnormal control plasmas (Thrombosis Reference Centre, Manchester, UK) at each time of testing.
Assays of factors II, V, VII, and X were performed by standard one stage methods on fresh plasma samples and on those obtained by centrifugation of the whole blood stored for 24 and 48 hours.
STATISTICS
The results from stored samples were compared with baseline values using paired t tests and Bland and Altman plots. 7 The data were examined further to determine the distribution of patients within specific INR ranges and to observe whether there were any changes in this distribution following storage for 24 or 48 hours.
Results
Control plasma results were within specified limits for each system. Table 1 gives the system ISI and MNPT values for all the combinations employed. Figure 1 shows Bland and Altman plots comparing stored sample INR to baseline values. After 24 hours the majority of plasmas showed little change with any of the systems, although some plasmas had altered by more than 0.5 INR. These were: one with RBT 1010, two with CCR 10, three with Manchester reagent, and two with Recombiplastin. None of the plasmas altered by this amount using the IL system. By 48 hours , however, more plasmas showed significant change from baseline: 12 with RBT 1010, eight with CCR 10, eight with Manchester reagent, two with recombiplastin, and four with the IL system. Table 2 shows the mean INR obtained with each system at baseline and after 24 and 48 hours. All give small but statistically significant diVerences after storage even for 24 hours. The diVerences increased markedly by 48 hours especially with the systems incorporating RBT 1010, CCR 10, Manchester reagent, and PT Fibrinogen HS Plus. The system incorporating Recombiplastin showed only a small mean change (0.11 INR) after 48 hours.
In table 3 These changes resulted in movement of patients between INR ranges following storage. This was particularly noticeable with the Manchester reagent/KC 10 system, where no patients with INR of more than 4.5 were found when INR was determined on fresh plasmas, while there were two after 24 hours and four after 48 hours.
There were small but statistically significant changes in factor levels between baseline and 24 hour stored samples, with the notable exception of factor V (table 4). Between baseline and 48 hour storage the diVerences were all statistically significant but still small-less than 10% for factor V, for example.
Discussion
At first glance, this study suggests that delay between blood collection and testing the prothrombin time is probably not of concern in anticoagulant dose adjustment. This is the likely conclusion based on comparison of the mean change in INR between freshly drawn samples and those obtained after 24 hours of storage. Unfortunately, there are some patients whose INR falls outside our arbitrary acceptable diVerence of 0.5 INR and who are overlooked when only the mean results are considered. This represents 2.5% of patients with RBT 1010, 5% with CCR 10, 7.5% with Manchester reagent, and 5% with recombiplastin. By 48 hours, this had risen to 30% of patients with RBT 1010, 20% with CCR 10 and Manchester reagent, and 10% with the IL system. With recombiplastin the numbers were unchanged at 48 hours.
Interestingly the thromboplastin employed seems to aVect the degree by which the INR is increased on storage, Recombiplastin and PT Fibrinogen HS Plus showing smaller change than Manchester reagent, Manchester combined capillary reagent, and RBT 1010.
Baglin and Luddington 8 concluded that there was no clinically significant change in INR when analysis was delayed for up to three days. Their conclusions, however, were based on mean INR diVerences and may have missed the occasional patient who behaved diVerently.
The Bland and Altman technique was particularly useful, since all the data were considered and shown individually. From these plots it was possible to identify the few patients whose INR changed dramatically on storage. These changes would have resulted in significant dose alteration.
Baglin and Luddington 8 also noted that although there were some variations in stability of results with diVerent thromboplastins, these diVerences over time for each thromboplastin were much less than the diVerences between thromboplastins. In the present study the diVerences between systems were reduced by performing local calibrations of the reagent and coagulometer combinations.
Another possible reason for the diVerences between Baglin and Luddington's study and ours is that blood was collected by diVerent methods, Sarstedt Monovet tubes being preferred by Baglin, while we used Vacutainers. Hernandez et al have also reported on this subject, 9 but, like Baglin and Luddington, they only gave mean INR values, making complete interpretation of their results diYcult.
There were only small decreases in the levels of factors II, V, VII, and X and it is unlikely that these would provide the reason for the changes in INR seen with some of the patients.
In conclusion after storing samples for only 24 hours, some patients' INR values may have changed suYciently to result in anticoagulant dose adjustment. In view of these observations, we cannot support this practice. 
